|
|
||||||||

,
,¶

,#
,
,¶
* Division of Immunology, Karp Laboratories, Childrens Hospital and
Department of Pathology and
Department of Dermatology, Harvard Medical School, Boston, MA 02115;
Immunology Program and School of Medicine, Stanford University, Stanford, CA 94305;
¶ Department of Dermatology, Brigham and Womens Hospital, Boston, MA 02115;
|| Department of Chemistry and Biochemistry, Brigham Young University, Provo, UT 84602; and
# Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305
iNKT cells are required for the induction of airway hyperreactivity (AHR), a cardinal feature of asthma, but how iNKT cells traffic to the lungs to induce AHR has not been previously studied. Using several models of asthma, we demonstrated that iNKT cells required the chemokine receptor CCR4 for pulmonary localization and for the induction of AHR. In both allergen-induced and glycolipid-induced models of AHR, wild-type but not CCR4–/– mice developed AHR. Furthermore, adoptive transfer of wild-type but not CCR4–/– iNKT cells reconstituted AHR in iNKT cell-deficient mice. Moreover, we specifically tracked CCR4–/– vs wild-type iNKT cells in CCR4–/–:wild-type mixed BM chimeric mice in the resting state, and when AHR was induced by protein allergen or glycolipid. Using this unique model, we showed that both iNKT cells and conventional T cells required CCR4 for competitive localization into the bronchoalveolar lavage/airways compartment. These results establish for the first time that the pulmonary localization of iNKT cells critical for the induction of AHR requires CCR4 expression by iNKT cells.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 These studies were supported by National Institutes of Health Grants 2R01AI046784-07A1 (to J.J.C.), R01 HL62348 (to D.T.U.), and R01 AI26322 (to D.T.U.). M.A.W. was supported by the Crohns and Colitis Foundation of America Research Fellowship (New York, NY).
2 E.C.B., J.J.C., and D.T.U contributed equally to this work.
3 Address correspondence and reprint requests to Dr. Dale T. Umetsu, Division of Immunology, Karp Laboratories, Childrens Hospital, Harvard Medical School, Room 10127, One Blackfan Circle, Boston, MA 02115. E-mail address: dale.umetsu{at}childrens.harvard.edu
4 Abbreviations used in this paper: AHR, airway hyperreactivity; BAL, bronchoalveolar lavage;
-GalCer,
-galactosylceramide; i.n., intranasal(ly); FSC, forward scatter; SSC, side scatter; WT, wild type; TARC, thymus and activation-regulated chemokine; MDC, macrophage-derived chemokine; BM, bone marrow.
This article has been cited by other articles:
![]() |
A. Terashima, H. Watarai, S. Inoue, E. Sekine, R. Nakagawa, K. Hase, C. Iwamura, H. Nakajima, T. Nakayama, and M. Taniguchi A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity J. Exp. Med., November 24, 2008; 205(12): 2727 - 2733. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Germanov, L. Veinotte, R. Cullen, E. Chamberlain, E. C. Butcher, and B. Johnston Critical Role for the Chemokine Receptor CXCR6 in Homeostasis and Activation of CD1d-Restricted NKT Cells J. Immunol., July 1, 2008; 181(1): 81 - 91. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Fang, B. Adkins, V. Deyev, and E. R. Podack Essential role of TNF receptor superfamily 25 (TNFRSF25) in the development of allergic lung inflammation J. Exp. Med., May 12, 2008; 205(5): 1037 - 1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Akbari, P. Stock, E. H. Meyer, G. J. Freeman, A. H. Sharpe, D. T. Umetsu, and R. H. DeKruyff ICOS/ICOSL Interaction Is Required for CD4+ Invariant NKT Cell Function and Homeostatic Survival J. Immunol., April 15, 2008; 180(8): 5448 - 5456. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |